Seeking Alpha

Drug developer Synageva BioPharma (GEVA) drops 2.1% AH after announcing a $60M stock offering -...

Drug developer Synageva BioPharma (GEVA) drops 2.1% AH after announcing a $60M stock offering - equal to 13.6% of its market cap as of today's close. The company only says it plans to use the proceeds for "general corporate purposes." (prospectus)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs